← Leaderboards
Xiaohua Li
University Of Alabama At Birmingham
$2,355,550
Attributed
$2,355,550
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.5K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,355,550 · 4
By mechanism
R01$967,881 · 1
K08$858,924 · 1
K02$383,745 · 1
R03$145,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Richard S Jope$9,870,186
- Lucas D. Pozzo-Miller$11,258,443
- Keith H Nuechterlein$31,385,871
- Eleonore Beurel$7,525,473
- Ricardo Azziz$5,301,766
Others in their field
Top investigators on “Lithium”
- David B Collum · Cornell University Ithaca$14,340,104
- Jeffrey M Testani · Yale University$14,153,479
- M. Stanley Whittingham · Suny At Binghamton$11,395,562
- Meera Sampath · Suny At Binghamton$9,956,488
- Olga Petrova · Suny At Binghamton$9,956,488
- Andrew A Nierenberg · Massachusetts General Hospital$9,784,863
Research focus
LithiumMood DisordersBrainAnticonvulsantsValproateBehavioralLamotrigineMolecular TargetImpairmentFundingBaseAcuteInterestAnimalsAntidepressive AgentsEnzymesAffectBipolar DisorderDoseAntipsychotic AgentsArchitectureGlycogen Synthase Kinase 3Functional DisorderMonoamine
Grant awards (14)
Behavioral manifestation and therapeutic implication of GSK3$127,915
K02 · FY2011 · MH · contact PI
Behavioral manifestation and therapeutic implication of GSK3$127,915
K02 · FY2010 · MH · contact PI
GSK3: Neural Modulators and Mood Disorders$240,177
R01 · FY2009 · MH · contact PI
Behavioral manifestation and therapeutic implication of GSK3$127,915
K02 · FY2009 · MH · contact PI
GSK3: Neural Modulators and Mood Disorders$240,177
R01 · FY2008 · MH · contact PI
GSK3: Neural Modulators and Mood Disorders$240,177
R01 · FY2007 · MH · contact PI
Glucogen Synthase Kinase 3beta and Bipolar Disorder$172,195
K08 · FY2007 · MH · contact PI
GSK3: Neural Modulators and Mood Disorders$247,350
R01 · FY2006 · MH · contact PI
Glucogen Synthase Kinase 3beta and Bipolar Disorder$172,195
K08 · FY2006 · MH · contact PI
Glucogen Synthase Kinase 3beta and Bipolar Disorder$171,912
K08 · FY2005 · MH
Regulation of GSK3beta by Mood Stabilizers$72,500
R03 · FY2005 · MH
Glucogen Synthase Kinase 3beta and Bipolar Disorder$171,507
K08 · FY2004 · MH
Regulation of GSK3beta by Mood Stabilizers$72,500
R03 · FY2004 · MH
Glucogen Synthase Kinase 3beta and Bipolar Disorder$171,115
K08 · FY2003 · MH